Loading
Life sciences · Journal article
Jsfa Reports · September 16, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract The dietary and lifestyle practices have predominantly compromised human health, which are influenced by modernization and industrialization. Hypercholesterolemia, caused by the consumption of fatty and fried foods and a sedentary lifestyle, is a major modifiable risk factor for cardiovascular disease and commonly coexists with obesity, diabetes, and other metabolic disorders. This review evaluates the anti‐hypercholesterolemic and other metabolic effects of barley, with particular emphasis on β‐glucan. Literature published between January 2015 to December 2025 was retrieved from online databases, such as PubMed, Scopus, Google Scholar, and ScienceDirect. Evidence from experimental and clinical studies reveals that barley consumption can reduce total cholesterol, low‐density lipoprotein cholesterol, and triglyceride levels while supporting glycemic control, intestinal function, and weight management. These effects are primarily attributed to barley β‐glucan, which increases intestinal viscosity, reduces cholesterol and fat absorption, enhances bile acid excretion, and undergoes colonic fermentation to produce short‐chain fatty acids that influence hepatic cholesterol metabolism. Other barley constituents, including phenolic compounds, phytosterols, tocopherols, and tocotrienols, may further contribute to antioxidant and lipid‐modulating activities. Overall, barley and barley‐derived β‐glucan show potential as functional‐food components for managing hypercholesterolemia and associated metabolic disorders. Their inclusion in a balanced diet may provide a practical food‐based approach to improving cardiometabolic health.